IBM stock tests $240 as OpenAI partnership supports recovery

IBM stock tests $240 as OpenAI partnership supports recovery
OpenAI partnership adds support to IBM’s rebound.

​IBM is recovering after its decline toward $230, while a new strategic partnership with OpenAI adds a strong fundamental catalyst. The stock returned to around $239 in premarket trading, making $240 the key level for extending the rebound.

IBM announced a strategic partnership with OpenAI aimed at accelerating the adoption of AI across enterprise operations. OpenAI frontier models, including GPT-5.6, as well as Codex and ChatGPT Work, will be integrated into IBM Consulting Advantage to support application modernization, workflow automation, and stronger cybersecurity.

IBM will also establish a dedicated OpenAI Practice, under which thousands of consultants and engineers will receive specialized training through the OpenAI Partner Network.

$240 becomes the key level for the next recovery attempt

IBM stock failed to hold above $240 and, as previously expected, returned to support near $230. In today’s premarket trading, however, buyers pushed the price back toward $239.

The key level during the regular session is $240. A decisive break and sustained move above this threshold would extend the recovery momentum and bring $244 back into focus as the nearest target.

A break above $244 would improve the short-term structure and open the way for further upside. The next medium-term target would then be the 50-day SMA near $255.70.

Move toward the 50-day SMA could confirm improving momentum 

IBM’s recovery from the sharp post-earnings sell-off remains intact, while the OpenAI partnership adds fundamental support to the move. The current structure, however, still sits somewhere between a conventional technical rebound and the early stages of a more durable recovery.

A sustained move above $244 would provide the first more convincing signal in favor of the latter scenario, while an advance toward the 50-day SMA near $255.70 would strengthen that case further.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.